We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
Our policy
Under what is known as a Shared Care Agreement (SCA), we may provide prescribing and monitoring for certain medication that is recommended by hospital teams or NHS affiliated companies. Each decision to enter into a SCA is taken on a case by case basis, and it is essential the recommended monitoring criteria are agreed to and met by the patient, and that the patient remains under specialist supervision. This includes medication for ADHD, as well as several rheumatological, dermatological and gastroenterological conditions.
Where monitoring is not adhered to, this can put the GP in a difficult situation, providing medication that is not being properly monitored. We therefore reserve the right to stop providing prescriptions in this situation, but would always do our best to try and liaise with the patient to ensure monitoring can continue before taking this step.
If a patient is transferred to our care from a different NHS service where a SCA is in place, we will honour this where it is safe to do so (monitoring up to date and within range), within local guidance, and we will refer the patient into the local service. If the transfer to our care is from a private provider, or from overseas, we will not enter into a SCA.